Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DOC
DOC logo

DOC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Healthpeak Properties, Inc (DOC) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast DOC stock price to fall
12 Analyst Rating
Wall Street analysts forecast DOC stock price to fall
6 Buy
6 Hold
0 Sell
Moderate Buy
Current: 19.400
sliders
Low
16.71
Averages
19.23
High
21
Current: 19.400
sliders
Low
16.71
Averages
19.23
High
21
Raymond James
Market Perform
initiated
AI Analysis
2026-06-16
New
Reason
Raymond James
Price Target
AI Analysis
2026-06-16
New
initiated
Market Perform
Reason
Raymond James resumed coverage of Healthpeak Properties with a Market Perform rating and no price target. The firm sees flattish earnings growth into the second half of 2027 for the company. "Choppy" life science leasing could restrain the stock's near-term performance, the analyst tells investors in a research note.
BMO Capital
Outperform
maintain
$20 -> $24
2026-06-15
New
Reason
BMO Capital
Price Target
$20 -> $24
2026-06-15
New
maintain
Outperform
Reason
BMO Capital raised the firm's price target on Healthpeak Properties to $24 from $20 and keeps an Outperform rating on the shares as part of a broader research note on US Real Estate and Skilled Nursing Facilities. BMO notes that it's hard to have a firm view on the merits of the allegations, but the firm is taking to heart that REITs have solid rent coverage levels, insulating them from potential downside, with strong supply/demand fundamentals, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOC
Unlock Now

People Also Watch